Get started
Author

Kaoru Murakami

Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies
2019 · Yuki Kita, Akihiro Hamada, et al. · British Journal of Cancer · 63
PDF
PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity
2022 · Hideki Furuya, Yuka Sasaki, et al. · Scientific Reports · 27
PDF
Trp53 Mutation in Keratin 5 (Krt5)-Expressing Basal Cells Facilitates the Development of Basal Squamous-Like Invasive Bladder Cancer in the Chemical Carcinogenesis of Mouse Bladder
2020 · Norihiko Masuda, Kaoru Murakami, et al. · American Journal Of Pathology · 24
PDF
MRI/RNA-Seq-Based Radiogenomics and Artificial Intelligence for More Accurate Staging of Muscle-Invasive Bladder Cancer
2023 · Touseef Ahmad Qureshi, Xingyu Chen, et al. · International Journal of Molecular Sciences · 17
Antitumor effect of WEE1 blockade as monotherapy or in combination with cisplatin in urothelial cancer
2021 · Kaoru Murakami, Yuki Kita, et al. · Cancer Science · 13
Sequential Use of Androgen Receptor Axis-targeted Agents in Chemotherapy-naive Castration-resistant Prostate Cancer: A Multicenter Retrospective Analysis With 3-Year Follow-up
2019 · Takashi Kobayashi, Naoki Terada, et al. · Clinical Genitourinary Cancer · 12
Bladder cancer risk stratification with the Oncuria 10-plex bead-based urinalysis assay using three different Luminex xMAP instrumentation platforms
2024 · Hideki Furuya, Toru Sakatani, et al. · Journal of Translational Medicine · 11
PDF
Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer outcomes in patients without radical cystectomy
2021 · Kota Iida, Makito Miyake, et al. · International Journal of Clinical Oncology · 10
Efficacy of Immediate Postoperative Instillation of Chemotherapy for Primary Non–Muscle-Invasive Bladder Cancer in Real-World Clinical Practice
2019 · Kaoru Murakami, Akihiro Hamada, et al. · Clinical Genitourinary Cancer · 10
Association of SNPs in the PAI1 Gene with Disease Recurrence and Clinical Outcome in Bladder Cancer
2023 · Kaoru Murakami, Hideki Furuya, et al. · International Journal of Molecular Sciences · 7
PDF
Clinical Utility of Oncuria™, a Multiplexed Liquid Biopsy for the Non-Invasive Detection of Bladder Cancer—A Pilot Study
2022 · Kaoru Murakami, Ian Pagano, et al. · Diagnostics · 7
PDF
Influencing Factors on the Oncuria™ Urinalysis Assay: An Experimental Model
2021 · Kaoru Murakami, Ian Pagano, et al. · Diagnostics · 7
PDF
Successful renal transplantation for end-stage renal insufficiency developed in a patient with Castleman's disease
2013 · Kaoru Murakami, Takashi Kobayashi, et al. · Transplant International · 6
Real-world effectiveness and treatment (tx) patterns in patients (pts) with locally advanced/metastatic urothelial carcinoma (la/mUC) receiving avelumab first-line maintenance (1LM) in Japan: Results from the JAVEMACS chart review study.
2025 · Hiroshi Kitamura, Takashi Kobayashi, et al. · Journal of Clinical Oncology · 5
PDF
Current trends in the promising immune checkpoint inhibition and radiotherapy combination for locally advanced and metastatic urothelial carcinoma
2023 · Takeshi Sano, Ryoichi Saito, et al. · International Journal of Clinical Oncology · 5
Case Study of Noni Extract in Men with Very Low-Risk or Low-Risk Prostate Cancer.
2021 · Yosuke Hirasawa, Ian Pagano, et al. · PubMed · 5
Enhancement of transduction efficiency using Adeno-associated viral vectors by chemical pretreatment to mice bladder urothelium
2020 · Akihiro Hamada, Yuki Kita, et al. · Journal of Virological Methods · 5
Comparative Analysis of CT and MRI Combined with RNA Sequencing for Radiogenomic Staging of Bladder Cancer
2025 · Joshua Levy, Toru Sakatani, et al. · International Journal of Molecular Sciences · 4
PDF
Safety and Efficacy of Prophylactic Topical Steroid Administration for Enfortumab Vedotin–related Cutaneous Toxicity
2024 · Yuki Kita, Takashi Nomura, et al. · European Urology Open Science · 4
A Diagnostic Gene Expression Signature for Bladder Cancer Can Stratify Cases into Prescribed Molecular Subtypes and Predict Outcome
2022 · Runpu Chen, Ian Pagano, et al. · Diagnostics · 4
PDF
Highly hypofractionated biaxially rotational dynamic radiation therapy ( BROAD ‐ RT ) for high‐risk prostate cancer
2025 · Rihito Aizawa, Takashi Ogata, et al. · Cancer Science · 3
PDF
Effects of Different Voided Urine Sample Storage Time, Temperature, and Preservatives on Analysis with Multiplex Bead-Based Oncuria Bladder Cancer Immunoassay
2025 · Sunao Tanaka, Kaoru Murakami, et al. · Diagnostics · 3
PDF
Clinical Validation of a Multiplex Urine Biomarker Assay for Surveillance of Recurrent Bladder Cancer
2026 · Yair Lotan, Michael Luu, et al. · Clinical Cancer Research · 2
JAVEMACS: a real-world study of avelumab maintenance therapy for advanced urothelial carcinoma in Japan
2025 · H. Kitamura, T. Kobayashi, et al. · ESMO Real World Data and Digital Oncology · 2
PDF
PTEN loss drives p53 LOH and immune evasion in a novel urothelial organoid model harboring p53 missense mutations
2025 · Akihiro Hamada, Yuki Kita, et al. · Oncogene · 2
Works count: 70
Citation count: 271
H-index: 9
I10-index: 9
Year
Topic
Type